By Barbara Arone, Vice President, Real World Solutions, IQVIA The use of real-world evidence (RWE) in the development of pharmaceutical treatments has grown exponentially in the past 10 years, fueled by availability of higher quality data, trial competitiveness and growing investments in personalized and
MoreWith the rapid development of biotechnology and molecular medicine, the introduction of mRNA as a vaccine or therapeutic agent enables
MoreBy Barbara Arone, Vice President, Real World Solutions, IQVIA The use of real-world evidence (RWE) in the development of pharmaceutical
MoreAs we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside
More